Comparison of efficacy and safety between gatifloxacin and levofloxacin in treatment of patients with light to moderate acute lower respiratory tract infections / 中国临床药理学与治疗学
Article
de Zh
| WPRIM
| ID: wpr-554135
Bibliothèque responsable:
WPRO
ABSTRACT
0.05 ), bacterial clearance were 100% and 90%, and adverse reaction rates were 10%(2/20)and 10.53 % ( 2/19 ), respectively. All those adverse reactions were mainly gastrointestinal tract reactions. The abnormality of laboratory inspections associated with trial drugs happened to 4 and 5 patients in two groups. The reactions were mostly light increase of aminotransferase without effect on therapy. CONCLUSION: Gatifloxacin is an antibiotic with large antimicrobial spectrum and can be recommended to treat light to moderate acute lower respiratory tract infections.
Texte intégral:
1
Indice:
WPRIM
langue:
Zh
Texte intégral:
Chinese Journal of Clinical Pharmacology and Therapeutics
Année:
1999
Type:
Article